[Federal Register Volume 71, Number 231 (Friday, December 1, 2006)]
[Notices]
[Pages 69589-69590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-20339]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 25, 2006, Chattem 
Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedule I and II:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)................  I
2,5-Dimethoxyamphetamine (7396)..........  I
4-Methoxyamphetamine (7411)..............  I
Difenoxin (9168).........................  I
Dihydromorphine (9145)...................  I
Amphetamine (1100).......................  II
Methamphetamine (1105)...................  II
Methylphenidate (1724)...................  II
Pentobarbital (2270).....................  II
Secobarbital (2315)......................  II
Codeine (9050)...........................  II
Dihydrocodeine (9120)....................  II
Oxycodone (9143).........................  II
Hydromorphone (9150).....................  II
Diphenoxylate (9170).....................  II
Hydrocodone (9193).......................  II
Meperidine (9230)........................  II
Dextropropoxyphene, bulk (non-dosage       II
 forms) (9273).
Morphine (9300)..........................  II
Thebaine (9333)..........................  II
Opium Extracts (9610)....................  II
Opium Fluid Extract (9620)...............  II
Opium Tincture (9630)....................  II
Opium, Granulated (9640).................  II
Oxymorphone (9652).......................  II
Noroxymorphone (9668)....................  II
Opium, Powdered (9639)...................  II
Alfentanil (9737)........................  II
Sufentanil (9740)........................  II
Fentanyl (9801)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR Sec.  1301.33(a).

[[Page 69590]]

    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than January 30, 2007.

    Dated: November 21, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-20339 Filed 11-30-06; 8:45 am]
BILLING CODE 4410-09-P